Mwanzo300601 • SHE
add
Shenzhen Kangtai Biological Prods Co Ltd
Bei iliyotangulia
¥ 15.59
Bei za siku
¥ 15.31 - ¥ 15.67
Bei za mwaka
¥ 13.10 - ¥ 21.12
Thamani ya kampuni katika soko
17.49B CNY
Wastani wa hisa zilizouzwa
12.41M
Uwiano wa bei na mapato
-
Mgao wa faida
0.58%
Ubadilishanaji wa msingi
SHE
Habari za soko
CNBC
saa 10 zilizopita
These stocks could be added to the S&P 500 when benchmark reshuffles this month
0.30%
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CNY) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 671.38M | -17.74% |
Matumizi ya uendeshaji wa biashara | 425.29M | -2.76% |
Mapato halisi | 11.62M | -93.74% |
Kiwango cha faida halisi | 1.73 | -92.40% |
Mapato kwa kila hisa | — | — |
EBITDA | 212.79M | -40.14% |
Asilimia ya kodi ya mapato | -3,472.08% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CNY) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 1.65B | 431.20% |
Jumla ya mali | 14.13B | -2.63% |
Jumla ya dhima | 4.52B | -5.87% |
Jumla ya hisa | 9.61B | — |
hisa zilizosalia | 1.12B | — |
Uwiano wa bei na thamani | 1.81 | — |
Faida inayotokana na mali | 2.39% | — |
Faida inayotokana mtaji | 2.94% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CNY) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 11.62M | -93.74% |
Pesa kutokana na shughuli | 286.87M | 60.54% |
Pesa kutokana na uwekezaji | 676.05M | 357.44% |
Pesa kutokana na ufadhili | -44.23M | -4.17% |
Mabadiliko halisi ya pesa taslimu | 918.51M | 825.91% |
Mtiririko huru wa pesa | -1.08B | 43.85% |
Kuhusu
Shenzhen Kangtai Biological Products, also known as BioKangtai, is a Chinese biopharmaceutical company that develops, manufactures and markets vaccines and other vaccine products.
Kangtai develops the Minhai COVID-19 vaccine and has the exclusive right to manufacture the Oxford–AstraZeneca COVID-19 vaccine in mainland China. Wikipedia
Ilianzishwa
8 Sep 1992
Tovuti
Wafanyakazi
1,913
